227 related articles for article (PubMed ID: 24397362)
1. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL
ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.
Hansen M; Jacobsen SE; Plunkett S; Liebscher GE; McCorvy JD; Bräuner-Osborne H; Kristensen JL
Bioorg Med Chem; 2015 Jul; 23(14):3933-7. PubMed ID: 25583099
[TBL] [Abstract][Full Text] [Related]
3. 5-HT
Leth-Petersen S; Petersen IN; Jensen AA; Bundgaard C; Bæk M; Kehler J; Kristensen JL
ACS Chem Neurosci; 2016 Nov; 7(11):1614-1619. PubMed ID: 27564969
[TBL] [Abstract][Full Text] [Related]
4. 5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines.
Toro-Sazo M; Brea J; Loza MI; Cimadevila M; Cassels BK
PLoS One; 2019; 14(1):e0209804. PubMed ID: 30629611
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
[TBL] [Abstract][Full Text] [Related]
6. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
7. Effect of Bulky
Soares BA; Yempala T; Martínez-Afani D; Acevedo-Fuentes W; Brea J; Loza MI; Cimadevila M; Cassels BK
ACS Chem Neurosci; 2024 Feb; 15(3):608-616. PubMed ID: 38241462
[TBL] [Abstract][Full Text] [Related]
8. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
Elmore JS; Decker AM; Sulima A; Rice KC; Partilla JS; Blough BE; Baumann MH
Neuropharmacology; 2018 Nov; 142():240-250. PubMed ID: 29501528
[TBL] [Abstract][Full Text] [Related]
9. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.
Prabhakaran J; Underwood MD; Kumar JS; Simpson NR; Kassir SA; Bakalian MJ; Mann JJ; Arango V
Bioorg Med Chem Lett; 2015 Sep; 25(18):3933-6. PubMed ID: 26253634
[TBL] [Abstract][Full Text] [Related]
11. N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.
Nichols DE; Sassano MF; Halberstadt AL; Klein LM; Brandt SD; Elliott SP; Fiedler WJ
ACS Chem Neurosci; 2015 Jul; 6(7):1165-75. PubMed ID: 25547199
[TBL] [Abstract][Full Text] [Related]
12. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes.
Cummings DF; Canseco DC; Sheth P; Johnson JE; Schetz JA
Bioorg Med Chem; 2010 Jul; 18(13):4783-92. PubMed ID: 20570529
[TBL] [Abstract][Full Text] [Related]
14. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
[TBL] [Abstract][Full Text] [Related]
15. Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.
Juncosa JI; Hansen M; Bonner LA; Cueva JP; Maglathlin R; McCorvy JD; Marona-Lewicka D; Lill MA; Nichols DE
ACS Chem Neurosci; 2013 Jan; 4(1):96-109. PubMed ID: 23336049
[TBL] [Abstract][Full Text] [Related]
16. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of [
Prabhakaran J; Solingapuram Sai KK; Zanderigo F; Rubin-Falcone H; Jorgensen MJ; Kaplan JR; Tooke KI; Mintz A; Mann JJ; Kumar JSD
Bioorg Med Chem Lett; 2017 Jan; 27(1):21-23. PubMed ID: 27889455
[TBL] [Abstract][Full Text] [Related]
18. Design and Discovery of Functionally Selective Serotonin 2C (5-HT
Cheng J; McCorvy JD; Giguere PM; Zhu H; Kenakin T; Roth BL; Kozikowski AP
J Med Chem; 2016 Nov; 59(21):9866-9880. PubMed ID: 27726356
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.
Fevig JM; Feng J; Rossi KA; Miller KJ; Wu G; Hung CP; Ung T; Malmstrom SE; Zhang G; Keim WJ; Cullen MJ; Rohrbach KW; Qu Q; Gan J; Pelleymounter MA; Robl JA
Bioorg Med Chem Lett; 2013 Jan; 23(1):330-5. PubMed ID: 23177783
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
